Profile
Henry Flanner worked as a Senior Director-Pharmaceutical Research at Middlebrook Pharmaceuticals, Inc. from 2003 to 2007.
He also worked as a Director-Drug Delivery Sciences at Shire Laboratories, Inc. and as a Vice President-Technical Operations at GlycoMimetics, Inc. Mr. Flanner received a graduate degree from The Johns Hopkins University and an undergraduate degree from the University of South Carolina.
Former positions of Henry Flanner
| Companies | Position | End |
|---|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Corporate Officer/Principal | 01/10/2007 |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Corporate Officer/Principal | - |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Chief Tech/Sci/R&D Officer | - |
Training of Henry Flanner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina
University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Commercial Services |
- Stock Market
- Insiders
- Henry Flanner
















